⌘K

Login Start Free

Home/Filings/4/0001600620-24-000072

4//SEC Filing

Leversage Jill 4

Accession 0001600620-24-000072

CIK 0001600620other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:09 PM ET

Size

4.6 KB

Accession

0001600620-24-000072

Insider Transaction Report

Form 4

Period: 2024-05-21

Aurinia Pharmaceuticals Inc.AUPH

Director

Transactions

Sale
Common Stock
2024-05-21$5.74/sh−5,610$32,201→ 12,918 total

Footnotes (1)

[F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.

Documents

1 file

4
wk-form4_1716408574.xmlPrimary
FORM 4

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1

filerCIK 0001837374

Filing Metadata

Form type: 4
Filed: May 21, 8:00 PM ET
Accepted: May 22, 4:09 PM ET
Size: 4.6 KB

View on SEC.gov